| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021954477 |
| P356 | DOI | 10.1038/SJ.BMT.1704769 |
| P698 | PubMed publication ID | 15640827 |
| P5875 | ResearchGate publication ID | 8090168 |
| P2093 | author name string | Mossad S | |
| Andresen S | |||
| Avery R | |||
| Bolwell B | |||
| Kalaycio M | |||
| Pohlman B | |||
| Sobecks R | |||
| Rybicki L | |||
| Jarvis J | |||
| P2860 | cites work | High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis | Q34237823 |
| Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 | ||
| High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical review | Q34685502 | ||
| Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria | Q40563612 | ||
| Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF). | Q40564199 | ||
| Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation. | Q40574813 | ||
| The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization | Q40575638 | ||
| Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis | Q40588563 | ||
| Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival | Q40596090 | ||
| An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose | Q40624714 | ||
| Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. | Q40629698 | ||
| Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors. | Q40639264 | ||
| High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer | Q74219120 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 375-381 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection | |
| P478 | volume | 35 |
| Q39006094 | Association between C-reactive protein levels in the first 1-3 days post-transplant and allogeneic immune reactions |
| Q79206227 | Engraftment syndrome after hematopoietic stem cell transplantation in multiple myeloma |
| Q38315390 | Engraftment syndrome: double-edged sword of hematopoietic cell transplants |
| Q40119879 | Favorable outcome to glucocorticoid therapy for engraftment syndrome in pediatric autologous hematopoietic cell transplant |
| Q53206127 | High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country. |
| Q91142736 | Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis |
| Q88506851 | Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation |
| Q36575315 | Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome |
| Q83885727 | Post-autologous hematopoietic SCT engraftment syndrome: a single center experience |
| Q99730640 | Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation |
Search more.